Andersen JT - Search Results

1

Developing the IVIG biomimetic, hexa-Fc, for drug and vaccine applications.

Czajkowsky DM, Andersen JT, Fuchs A, Wilson TJ, Mekhaiel D, Colonna M, He J, Shao Z, Mitchell DA, Wu G, Dell A, Haslam S, Lloyd KA, Moore SC, Sandlie I, Blundell PA, Pleass RJ. Czajkowsky DM, et al. Among authors: andersen jt. Sci Rep. 2015 Apr 27;5:9526. doi: 10.1038/srep09526. Sci Rep. 2015. PMID: 25912958 Free PMC article.

2

Prolonged and increased expression of soluble Fc receptors, IgG and a TCR-Ig fusion protein by transiently transfected adherent 293E cells.

Berntzen G, Lunde E, Flobakk M, Andersen JT, Lauvrak V, Sandlie I. Berntzen G, et al. Among authors: andersen jt. J Immunol Methods. 2005 Mar;298(1-2):93-104. doi: 10.1016/j.jim.2005.01.002. J Immunol Methods. 2005. PMID: 15847800

3

The conserved histidine 166 residue of the human neonatal Fc receptor heavy chain is critical for the pH-dependent binding to albumin.

Andersen JT, Dee Qian J, Sandlie I. Andersen JT, et al. Eur J Immunol. 2006 Nov;36(11):3044-51. doi: 10.1002/eji.200636556. Eur J Immunol. 2006. PMID: 17048273 Free article.

4

A strategy for bacterial production of a soluble functional human neonatal Fc receptor.

Andersen JT, Justesen S, Berntzen G, Michaelsen TE, Lauvrak V, Fleckenstein B, Buus S, Sandlie I. Andersen JT, et al. J Immunol Methods. 2008 Feb 29;331(1-2):39-49. doi: 10.1016/j.jim.2007.11.003. Epub 2007 Dec 10. J Immunol Methods. 2008. PMID: 18155020

5

A receptor-mediated mechanism to support clinical observation of altered albumin variants.

Andersen JT, Sandlie I. Andersen JT, et al. Clin Chem. 2007 Dec;53(12):2216. doi: 10.1373/clinchem.2007.097071. Clin Chem. 2007. PMID: 18267931 No abstract available.

6

Identification of a high affinity FcgammaRIIA-binding peptide that distinguishes FcgammaRIIA from FcgammaRIIB and exploits FcgammaRIIA-mediated phagocytosis and degradation.

Berntzen G, Andersen JT, Ustgård K, Michaelsen TE, Mousavi SA, Qian JD, Kristiansen PE, Lauvrak V, Sandlie I. Berntzen G, et al. Among authors: andersen jt. J Biol Chem. 2009 Jan 9;284(2):1126-35. doi: 10.1074/jbc.M803584200. Epub 2008 Oct 28. J Biol Chem. 2009. PMID: 18957413 Free article.

7

The versatile MHC class I-related FcRn protects IgG and albumin from degradation: implications for development of new diagnostics and therapeutics.

Andersen JT, Sandlie I. Andersen JT, et al. Drug Metab Pharmacokinet. 2009;24(4):318-32. doi: 10.2133/dmpk.24.318. Drug Metab Pharmacokinet. 2009. PMID: 19745559 Free article.

8

FcRn binding properties of an abnormal truncated analbuminemic albumin variant.

Andersen JT, Daba MB, Sandlie I. Andersen JT, et al. Clin Biochem. 2010 Mar;43(4-5):367-72. doi: 10.1016/j.clinbiochem.2009.12.001. Epub 2009 Dec 16. Clin Biochem. 2010. PMID: 20006594

9

Cross-species binding analyses of mouse and human neonatal Fc receptor show dramatic differences in immunoglobulin G and albumin binding.

Andersen JT, Daba MB, Berntzen G, Michaelsen TE, Sandlie I. Andersen JT, et al. J Biol Chem. 2010 Feb 12;285(7):4826-36. doi: 10.1074/jbc.M109.081828. Epub 2009 Dec 14. J Biol Chem. 2010. PMID: 20018855 Free PMC article.

10

Extending half-life by indirect targeting of the neonatal Fc receptor (FcRn) using a minimal albumin binding domain.

Andersen JT, Pehrson R, Tolmachev V, Daba MB, Abrahmsén L, Ekblad C. Andersen JT, et al. J Biol Chem. 2011 Feb 18;286(7):5234-41. doi: 10.1074/jbc.M110.164848. Epub 2010 Dec 7. J Biol Chem. 2011. PMID: 21138843 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

355 results

Search Page